The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles
Authors:
- 24 April 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 79 (6) , 714-723
Abstract
Because appropriate cell‐culture systems or small‐animal models have been lacking, the early steps in the HCV life cycle have been difficult to study. A cell culture system was developed recently that allows production of infectious HCV. In this study, infectious HCV particles produced in cultured cells were used. To clarify the role of CD81 in HCV attachment and entry, the effect of anti‐CD81 antibody was examined. The antibody blocked HCV virion entry but not particle attachment. Only the fraction bound to a heparin affinity column and eluted with 0.3 M NaCl productively infected Huh7 cells, indicating that infectious HCV particles bind to heparin. Both heparin treatment of the virus particles and heparinase treatment of the Huh7 cells reduced virus‐cell binding without substantially inhibiting HCV infectivity. Finally, to confirm the role of both heparin sulfate proteoglycan (HSPG) and CD81 in HCV entry, the effects of heparinase I and anti‐CD81 antibody were analyzed. No productive RNA replication was detected in the Huh7 cells in the presence of both heparinase I and anti‐CD81 antibody. In conclusion, these data suggested that both HSPG and CD81 are important for HCV entry. HSPG may play a role in the initial cell surface binding of infectious HCV particles and CD81 is conceivably correlated with HCV entry after viral attachment. J. Med. Virol. 79: 714–723, 2007.Keywords
This publication has 63 references indexed in Scilit:
- L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virusProceedings of the National Academy of Sciences, 2004
- Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger ReceptorJournal of Biological Chemistry, 2003
- Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan SulfateJournal of Biological Chemistry, 2003
- Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein ComplexesJournal of Experimental Medicine, 2003
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- The role of the hepatitis C virus glycoproteins in infectionReviews in Medical Virology, 2000
- Functional Characterization of Intracellular and Secreted Forms of a Truncated Hepatitis C Virus E2 GlycoproteinJournal of Virology, 2000
- Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptorProceedings of the National Academy of Sciences, 1999
- Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfateNature Medicine, 1997
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989